LI Xiangying, GANG Qiaojian, MU Liyuan, SHENG Yingda, HA Xiaoqin. Research progress of umbilical cord mesenchymal stem cell-derived exosomes in treatment of tumor[J]. Journal of Clinical Medicine in Practice, 2022, 26(23): 108-112, 118. DOI: 10.7619/jcmp.20222117
Citation: LI Xiangying, GANG Qiaojian, MU Liyuan, SHENG Yingda, HA Xiaoqin. Research progress of umbilical cord mesenchymal stem cell-derived exosomes in treatment of tumor[J]. Journal of Clinical Medicine in Practice, 2022, 26(23): 108-112, 118. DOI: 10.7619/jcmp.20222117

Research progress of umbilical cord mesenchymal stem cell-derived exosomes in treatment of tumor

  • Umbilical cord mesenchymal stem cells are multidirectional stem cells from the umbilical cord that can inhibit tumor development through exosomes. Exosomes secreted by umbilical cord mesenchymal stem cells play an anti-tumor role by participating in immune response, inhibiting tumor cell proliferation, reducing angiogenesis and improving drug sensitivity. However, there are few studies on the application of exosomes secreted by umbilical cord mesenchymal stem cells in tumor therapy. The paper reviewed the mechanism of action and application prospect of these drugs in tumor therapy.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return